Emanuela Palmerini

Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

Alessandro Gronchi, Aisha Miah, Angelo Paolo Dei Tos et al. · Annals of Oncology · 2021 · 879 citations · Full text

Surgical Oncology, Soft Tissue Surgery, Visceral Sarcomas +6

Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

Paolo G. Casali, Jean‐Yves Blay, N. Abecassis et al. · Annals of Oncology · 2021 · 509 citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Medicine +11

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo et al. · The Lancet Oncology · 2017 · 473 citations

Tumor Biology, Surgical Oncology, Malignant Disease +10

Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

William D. Tap, Hans Gelderblom, Emanuela Palmerini et al. · The Lancet · 2019 · 454 citations · Full text

Surgical Oncology, Oncology, Medicine +9

Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

Sandra J. Strauss, Anna Maria Frezza, N. Abecassis et al. · Annals of Oncology · 2021 · 408 citations · Full text

Bone Disease, Bone Sarcomas, Surgical Oncology +5